Integrated functional genomics approach for the design of patient-individual antitumor vaccines

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Identifying tumor-specific targets is crucial for effective cancer immunotherapy.
• Current methods may not fully capture the diversity of neoantigens presented by tumors.

Purpose of the Study:

• To identify novel tumor-associated T-cell epitopes in individual patients.
• To develop an integrated approach for personalized cancer vaccine design.

Main Methods:

• Performed expression profiling of tumor and normal tissues to identify differentially expressed genes.
• Utilized mass spectrometry to characterize Major Histocompatibility Complex (MHC) ligands from tumor samples.
• Combined genomic and proteomic data to identify potential T-cell epitopes.

Main Results:

• Identified numerous MHC ligands, with several derived from overexpressed genes, a proto-oncogene, and a frameshift mutation.
• Confirmed at least one identified peptide as a genuine T-cell epitope.
• Demonstrated the feasibility of proposing multiple candidates for peptide-based immunotherapy.

Conclusions:

• An integrated functional genomics approach combining expression profiling and mass spectrometry is effective for identifying tumor-associated T-cell epitopes.
• This method facilitates the design of personalized antitumor vaccines tailored to individual patients.
• The findings support the advancement of precision oncology through novel immunotherapeutic strategies.